A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma
Trial ID or NCT#
NCT01898598
Status
NOT RECRUITING
Purpose
This randomized, double-blind, placebo-controlled study will assess the efficacy and safety of vismodegib with surgery in participants with basal cell carcinoma.
Official Title
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study to Assess the Efficacy and Safety of Oral Vismodegib for the Treatment of Basal Cell Carcinoma Preceding Excision by Mohs Micrographic Surgery
Investigator(s)
Sumaira Z. Aasi, MD
Dermatologist,
Mohs surgeon,
Cutaneous oncology specialist,
Dermatologic surgeon
Clinical Professor, Dermatology
Jean Y Tang
General dermatologist,
Dermatologic oncologist,
Dermatologist,
Cutaneous oncology specialist
Professor of Dermatology
Contact us to find out if this trial is right for you.
Contact
CCTO
650-498-7061
View on ClinicalTrials.gov
